相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Relaxin and the Cardiovascular System: from Basic Science to Clinical Practice
Rafael Clara Martins et al.
CURRENT MOLECULAR MEDICINE (2020)
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction
Julio A. Chirinos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials
Thomas Bernd Dschietzig
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload
Mariana Pintalhao et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
The relationship of circulating relaxin-2 concentrations with short-term prognosis in patients with acute heart failure: the RELAHF study
Pablo Herrero-Puente et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review
Evelien E. S. van Riet et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2011)
N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure
C Fisher et al.
HEART (2003)